About NewLab Clinical Research Inc.
Clinical Trials at NewLab Clinical Research Inc.
During the past decade, NewLab Clinical Research Inc. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 9 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NewLab Clinical Research Inc." #1 sponsor was "Pfizer" with 4 trials, followed by "Galderma R&D" with 3 trials
sponsored, "Asana BioSciences" with 2 trials sponsored, "Innovaderm Research Inc." with 2 trials sponsored and "LEO Pharma"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NewLab Clinical Research Inc."
#1 collaborator was "Abbott" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Kyowa Kirin Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at NewLab Clinical Research Inc.
According to Clinical.Site data, the most researched conditions in "NewLab Clinical Research Inc." are
"Psoriasis" (7 trials), "Atopic Dermatitis" (3 trials), "Plaque Psoriasis" (3 trials), "Onychomycosis" (2 trials) and "Acne Vulgaris" (1 trials). Many other conditions were trialed in "NewLab Clinical Research Inc." in a lesser frequency.
Clinical Trials Intervention Types at NewLab Clinical Research Inc.
Most popular intervention types in "NewLab Clinical Research Inc." are "Drug" (20 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "CP-690,550" (4 trials), "ASN002" (2 trials), "ASKP1240" (1 trials) and "Adalimumab Every Week" (1 trials). Other intervention names were less common.
Clinical Trials Genders at NewLab Clinical Research Inc.
The vast majority of trials in "NewLab Clinical Research Inc." are
21 trials for "All" genders.
Clinical Trials Status at NewLab Clinical Research Inc.
Currently, there are NaN active trials in "NewLab Clinical Research Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in NewLab Clinical Research Inc.,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in NewLab Clinical Research Inc., 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".